Corticosteroids for COVID-19-Associated ARDS

Systemic corticosteroids have emerged as a possible therapy to mitigate lung injury in severe COVID-19 infection. Here, we provide historical context for corticosteroid administration in acute respiratory failure due to viral infection and review existing data for the use of systemic corticosteroids for SARS-CoV-2 infection. The results of these limited data consistently suggest a mortality benefit for patients with COVID-19-associated acute respiratory distress syndrome with no existing evidence to suggest harm.
Source: Clinical Pulmonary Medicine - Category: Respiratory Medicine Tags: Critical Care/Respiratory Care Source Type: research